Sinovac/ CoronaVac

Markiert sind besonders wichtige Quellen.

• EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated Share

  ema.europa.eu, hinzugefügt am 05.05.2021, wichtige Quelle

• Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

  thelancet.com, hinzugefügt am 15.02.2021, wichtige Quelle

• Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

  thelancet.com, hinzugefügt am 04.02.2021, wichtige Quelle

• Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study

  thelancet.com, hinzugefügt am 26.04.2022

• Sinovac Is 38% Effective In Shielding Kids From Covid, Data Show

  bnnbloomberg.ca, hinzugefügt am 17.03.2022

• Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

  nature.com, hinzugefügt am 21.02.2022

• CoronaVac und VLA2001: Wie gut schützen inaktivierte Impfstoffe vor Omikron?

  aerzteblatt.de, hinzugefügt am 17.02.2022

• Studie zu Chinas Coronavac Totimpfstoff wirkt nicht gegen Omikron

  n-tv.de, hinzugefügt am 29.12.2021

• People who take Sinovac vaccine at higher risk of severe disease from Covid-19: NCID-MOH study

  straitstimes.com, hinzugefügt am 17.12.2021

• Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

  thelancet.com, hinzugefügt am 13.12.2021

• Projeto S: A Stepped-Wedge Randomized Trial to Assess CoronaVac Effectiveness in Serrana, Brazil

  papers.ssrn.com, hinzugefügt am 04.12.2021

• A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2

  medrxiv.org, hinzugefügt am 25.11.2021

• A RCT of a third dose CoronaVac or BNT162b2 vaccine in adults with two doses of CoronaVac

  medrxiv.org, hinzugefügt am 05.11.2021

• CoronaVac induces lower neutralising activity against variants of concern than natural infection

  thelancet.com, hinzugefügt am 15.09.2021

• Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality

  thelancet.com, hinzugefügt am 24.08.2021

• Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, China

  papers.ssrn.com, hinzugefügt am 24.08.2021

• Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

  bmj.com, hinzugefügt am 24.08.2021

• China's Sinovac COVID-19 Vaccine Only 58% Effective Against COVID-19: Study

  ibtimes.com, hinzugefügt am 06.08.2021

• Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

  nature.com, hinzugefügt am 03.08.2021

• Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial

  medrxiv.org, hinzugefügt am 27.07.2021

• Antibodies from Sinovac's COVID-19 shot fade after about 6 months, booster helps - study

  reuters.com, hinzugefügt am 27.07.2021

• Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study

  thelancet.com, hinzugefügt am 20.07.2021

• SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients

  medrxiv.org, hinzugefügt am 17.07.2021

• Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

  thelancet.com, hinzugefügt am 09.07.2021

• Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

  nejm.org, hinzugefügt am 09.07.2021

• CoronaVac: Impfstoff aus China erzielt hohe Schutzwirkung in der Türkei und Chile

  aerzteblatt.de, hinzugefügt am 09.07.2021

• Leaked memo raises Thai concern about Sinovac vaccine's efficacy

  reuters.com, hinzugefügt am 07.07.2021

• Covid-19 Killed 26 Indonesian Doctors in June—at Least 10 Had Taken China’s Sinovac Vaccine

  wsj.com, hinzugefügt am 30.06.2021

• Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

  thelancet.com, hinzugefügt am 30.06.2021

• BioNTech shots have stronger antibody response than Sinovac, Hong Kong study shows - SCMP

  reuters.com, hinzugefügt am 21.06.2021

• Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

  jamanetwork.com, hinzugefügt am 06.06.2021

• Immunization of Serrana´s population with Butantan´s vaccine has a high decrease of 80% cases and 95% in deaths by COVID-19

  butantan.gov.br, hinzugefügt am 06.06.2021

• WHO lässt Impfstoff von Sinovac zu

  n-tv.de, hinzugefügt am 06.06.2021

• WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations

  who.int, hinzugefügt am 06.06.2021

• Sinovac’s COVID-19 vaccine gains China nod for emergency use in kids, adolescents

  reuters.com, hinzugefügt am 06.06.2021

• Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor

  medrxiv.org, hinzugefügt am 31.05.2021

• Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac

  thelancet.com, hinzugefügt am 28.05.2021

• Indonesia finds China’s Sinovac 100% effective against death in 28-day real world study

  theprint.in, hinzugefügt am 13.05.2021

• Alfie: "Preliminary" data from GACH suggest "similar" effects of Sinovac and Pfizer to reduce mortality from covid-19

  sarandi690.com.uy, hinzugefügt am 07.05.2021

• China’s COVID vaccines are going global — but questions remain

  nature.com, hinzugefügt am 05.05.2021

• WHO: Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine

  cdn.who.int, hinzugefügt am 04.05.2021

• In Brazil, alarm over no-shows for second Covid vaccine dose

  nbcnews.com, hinzugefügt am 29.04.2021

• Thailand sticks with Sinovac vaccine after cases of 'stroke-like' side effects

  reuters.com, hinzugefügt am 21.04.2021

• Performance of vaccination with CoronaVac in a cohort of healthcare workers (HCW) - preliminary report

  medrxiv.org, hinzugefügt am 16.04.2021

• In clinical and real world trials, China’s Sinovac underperforms

  economist.com, hinzugefügt am 16.04.2021

• SARS-CoV-2: Chinesischer Totimpfstoff schützt offenbar auch vor brasilianischer Variante

  aerzteblatt.de, hinzugefügt am 13.04.2021

• Sinovac vaccine effective against virus variants in Brazil; efficacy rises if injection interval is more than 21 days

  globaltimes.cn, hinzugefügt am 13.04.2021

• COVID-19 Vaccine Efficacy Questions

  blogs.sciencemag.org, hinzugefügt am 13.04.2021

• Top Chinese official admits vaccines have low effectiveness

  abcnews.go.com, hinzugefügt am 12.04.2021

• Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil

  sciencemag.org, hinzugefügt am 10.04.2021

• Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study

  medrxiv.org, hinzugefügt am 09.04.2021

• Incidência da Covid-19 em funcionários do HC de SP vacinados com a CoronaVac foi de 50,7% a 73,8% menor do que na população, diz USP

  g1.globo.com, hinzugefügt am 07.04.2021

• Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization

  nejm.org, hinzugefügt am 07.04.2021

• Interim Report: Safety And Immunogenicity Of An Inactivated Vaccine Against Sars-Cov-2 In Healthy Chilean Adults In A Phase 3 Clinical Trial

  medrxiv.org, hinzugefügt am 02.04.2021

• Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO

  reuters.com, hinzugefügt am 01.04.2021

• China’s vaccine diplomacy stumbles as clinical trial data remains absent

  washingtonpost.com, hinzugefügt am 24.03.2021

• Sinovac says its vaccine is safe for children as young as 3

  apnews.com, hinzugefügt am 23.03.2021

• Preliminary studies carried out by Butantan in vaccinated people demonstrate that Coronavac is able to neutralize variants of the new coronavirus

  butantan.gov.br, hinzugefügt am 11.03.2021

• Butantan says that CoronaVac is effective against the three variants of the coronavirus circulating in the country

  g1.globo.com, hinzugefügt am 11.03.2021

• Sinovac's COVID-19 shot is 83% effective, not 91%, Turkey says

  asia.nikkei.com, hinzugefügt am 04.03.2021

• Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use

  reuters.com, hinzugefügt am 03.03.2021

• Chinese vaccines sweep much of the world, despite concerns

  abcnews.go.com, hinzugefügt am 03.03.2021

• CoronaVac Vaccine By Sinovac : Your Questions Answered!

  techarp.com, hinzugefügt am 01.03.2021

• Sinovac vaccine works on UK, South African variants - Brazil institute

  reuters.com, hinzugefügt am 18.02.2021

• Single-Cell Sequencing and Immune Function Assays of Peripheral Blood Samples Demonstrate Positive Responses of an Inactivated SARS-CoV-2 Vaccine

  papers.ssrn.com, hinzugefügt am 15.02.2021

• Government of São Paulo Will Immunize The Entire Vaccinable Population of a Small Town to Assess The Effect on Covid

  www1.folha.uol.com.br, hinzugefügt am 10.02.2021

• SARS-CoV-2: Sinovac verkündet Ergebnisse aus Phase-3-Studie

  aerzteblatt.de, hinzugefügt am 10.02.2021

• Sinovac Announces Phase III Results of Its COVID-19 Vaccine

  sinovac.com, hinzugefügt am 06.02.2021

• Sinovac applies for conditional approval of COVID-19 vaccine in China

  asia.nikkei.com, hinzugefügt am 06.02.2021

• 3 Impfstoffe aus China drängen auf weltweiten Einsatz

  aerzteblatt.de, hinzugefügt am 04.02.2021

• China COVID vaccine reports mixed results — what does that mean for the pandemic?

  nature.com, hinzugefügt am 29.01.2021

• Raging virus, few shots. How Brazil missed its chance to secure COVID-19 vaccines

  reuters.com, hinzugefügt am 28.01.2021

• Johnson and Johnson, SinoVac and More

  blogs.sciencemag.org, hinzugefügt am 15.01.2021

• Wariness in Indonesia as Chinese Sinovac COVID-19 jabs start

  reuters.com, hinzugefügt am 15.01.2021

• Coronavirus: Turkey approves China’s Sinovac vaccine for emergency use

  scmp.com, hinzugefügt am 14.01.2021

• China's Sinovac defends COVID-19 vaccine after disappointing Brazil data

  reuters.com, hinzugefügt am 13.01.2021

• Singapore will review Sinovac Covid-19 vaccine carefully before possible roll-out: Gan Kim Yong

  straitstimes.com, hinzugefügt am 13.01.2021

• China's Sinovac vaccine has "general efficacy" of 50.4% in Brazil trials, says Butantan

  reuters.com, hinzugefügt am 12.01.2021

• Coronavirus: Brazil finds China’s Sinovac vaccine to be less effective than previous data shows

  scmp.com, hinzugefügt am 12.01.2021

• Sinovac's vaccine general efficacy less than 60% in Brazil trial - report

  reuters.com, hinzugefügt am 12.01.2021

• Indonesia says China’s Sinovac vaccine 65.3 per cent effective, grants emergency approval

  scmp.com, hinzugefügt am 12.01.2021

• Sinovac’s Vaccine Approved by Indonesia for Emergency Use

  bloomberg.com, hinzugefügt am 11.01.2021

• Sinovac, AstraZeneca seek vaccine approval in Brazil

  medicalxpress.com, hinzugefügt am 10.01.2021

• Sinovac vaccine 78% effective in Brazil trial, experts call for more details

  reuters.com, hinzugefügt am 08.01.2021

• Turkey and Brazil Say Chinese Vaccine Effective, With Sparse Supporting Data

  nytimes.com, hinzugefügt am 31.12.2020

Keine Quelle enthält diesen Text.